Organization
Bristol-Myers Squibb, NJ, United States
3 abstracts
Abstract
ABATACEPT DEMONSTRATES CONSISTENT SAFETY AND SUSTAINED IMPROVEMENTS IN EFFICACY THROUGH 5 YEARS OF TREATMENT IN BIOLOGIC-NAÏVE PATIENTS WITH RA Org: Center for Rheumatology, Albany Medical College, Albany, United States, University of Alberta Hospital, Edmonton, AB, Canada, University of Leeds, Leeds, United Kingdom, Rheumatology Hospital, San Luis Potosi, Mexico, Department of Rheumatology, Medical University of Wroclaw, Wroclaw, Poland,
Abstract
ABATACEPT IMPROVES DISEASE ACTIVITY STATUS OVER TIME IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE Org: Hosp Cochin, Descartes Univ, Paris, France, Albany Medical College, Albany, NY, United States, Bristol-Myers Squibb, Rueil-Malmaison, France, Bristol-Myers Squibb, NJ, United States, Univ of Leeds, Leeds, United Kingdom,
Abstract
ACTIVITY OF ABATACEPT IN SLE: RESULTS OF A 12-MONTH PHASE II EXPLORATORY STUDY Org: Hosp General de Mexico, Mexico City, Mexico, UZ Gasthuisberg, KU Leuven, Leuven, Belgium, The Rayne Institute, London, United Kingdom, Bristol-Myers Squibb, NJ, United States,